期刊文献+

依托泊苷聚乳酸微球的制备 被引量:1

Preparation of etoposide Polylactic Acid Microspheres
原文传递
导出
摘要 目的:用生物可降解材料聚乳酸制备依托泊苷微球,并对其体外释药特性进行研究。方法:采用乳化-溶剂扩散法制备依托泊苷聚乳酸微球,通过正交试验确定最佳处方工艺;采用紫外分光光度法测定微球载药量、包封率和体外药物释放,利用光学显微镜观察微球形态和粒径分布。结果:所得微球外观圆整,平均粒径为12.87μm,载药量为14.79%,药物包封率为61.09%,体外释药符合Higuchi方程。结论:依托泊苷聚乳酸微球制备工艺稳定,体外释药符合长效制剂特征。 Objective To prepare etoposide microspheres using thg biodegradable meterials-polylactic acid and to study its release characteristics in vitro.Methods The polylactic acid microspheres were prepared by emulsion-solvent diffusion method and the orthogonal test design was used to optimize the formulation and technology.The drug-loading,emcapsulation and release in vitro were determined by ultraviolet spectrophotometry and the appearance and particle size of microspheres was observed by light microscope.Results The shape of etoposide microspheres was spherical with mean particle size of 12.87 μm.The drug loading and encapsulation efficiency were 14.79% and 61.09%,respectively.The in vitro release characteristics of microspheres was found to agree with Higuchi equation.Conclusion The technology of preparation was successful and etoposide polylactic acid micropheres showed significant sustained release.
出处 《湖南师范大学学报(医学版)》 2011年第4期77-79,共3页 Journal of Hunan Normal University(Medical Sciences)
基金 湖南省教育厅资助科研项目(09C630)
关键词 依托泊苷 聚乳酸 微球 etoposide polylactic acid microspheres
  • 相关文献

参考文献6

二级参考文献12

共引文献24

同被引文献17

  • 1符旭东,高永良,平其能.制备工艺对石杉碱甲微球体外释药机制的影响[J].药学学报,2006,41(7):589-594. 被引量:2
  • 2王襄平,梅兴国.乳酸/羟基乙酸共聚物的分子量及其单体组成比例对利培酮微球性质的影响[J].中国药房,2007,18(1):38-41. 被引量:13
  • 3Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro re- lease of dexamethasone from PLGA microspheres [ J ]. J Control Release ,2008,127 (2) : 137.
  • 4Makino K, Nakajima T, Shikamura M. et al. Efficient in- tracellular delivery of rifampicin to alveolar maerophages using rifampiein-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampiein [ J ]. Colloids Surf B Biointerfaees, 2004,36 (1) :35.
  • 5Du L, Cheng J, Chi Q. et al. Biodegradable PLGA micro- spheres as a sustained release system for a new luteinizing hormone-releasing hormone ( LHRH ) antagonist [J]. Chem Pharm Bu11,2006,54(9) :1259.
  • 6Xuan J, Lin Y, Huang J, et al. Exenatide-loaded PLGA mi- crospheres with improved glycemic control :In vitro bioactivi-ty and in vivo pharmacokinetic pro? les after subcutaneous administration to SD rats [ J ]. Peptides ,2013 ,46 :172.
  • 7Diab R, Brillault J, Bardy A, et al. Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rif- ampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer:efficiency for ex vivo alveolar mac- rophage targeting [ J]. Int J Pharm,2012,436(1-2) :833.
  • 8Ravi S, Peh KK, Darwis Y, et al. Development and char- acterization of polymeric microspheres for controlled re- lease protein loaded drug delivery system [ J ]. Indian J Pharm Sei,2008,70 ( 3 ) :303.
  • 9闫莉萍,王海学,彭健.微球制剂的临床前药理毒理研究和评价[J].药物评价研究,2010,33(5):332-334. 被引量:7
  • 10张敏,高静,孙李平,武鑫,叶丽华,高申.丙氨瑞林微球制备工艺优化和体外释放研究[J].药学服务与研究,2012,12(5):358-361. 被引量:2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部